Xu Stella 4
4 · NextCure, Inc. · Filed Jun 15, 2020
Insider Transaction Report
Form 4
NextCure, Inc.NXTC
Xu Stella
Director
Transactions
- Award
Stock Option (Right to Buy)
2020-06-11+14,250→ 14,250 totalExercise: $24.13Exp: 2030-06-10→ Common Stock (14,250 underlying)
Footnotes (1)
- [F1]The option vests in full on the earlier of June 11, 2021 and the date of the 2021 Annual Meeting of Stockholders.